Posted on 2月 1, 20212/1/21
Iterum Therapeutics Announces Collaboration with EVERSANA to Support Oral Sulopenem Launch
Posted on 8月 10, 20208/10/20
FDA Approves Roche, PTC’s SMA Treatment, Evrysdi (Risdiplam)
Posted on 6月 11, 20206/11/20
FDA Approves BMS’ Opdivo for Advanced ESCC After Chemotherapy
Posted on 6月 3, 20206/3/20
FDA Sets September Review Date for Novartis’ Multiple Sclerosis Targeted B-Cell Therapy, Ofatumumab
Posted on 5月 26, 20205/26/20
FDA Grants Enhertu Orphan Drug Designation for Gastric Cancer
Posted on 5月 11, 20205/11/20
FDA OK’s AZ & Merck’s Lynparza Plus Bevacizumab in HRD-Positive Ovarian Cancer
Posted on 4月 8, 20204/8/20
FDA Grants Priority Review to Merck’s Keytruda, Use Based on Biomarker Regardless of Tumor Type
Posted on 2月 23, 20202/23/20